OPEN STUDIES
Cervical cancer
ENGOT-cx12/GCT1015-07
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin versus Investigator’s Choice Chemotherapy in Second or Third Line Metastatic or Recurrent Cervical Cancer.
GEICO 72-C/GTAC/ATOMICC (A Oaknin)
A phase II trial of Anti-PD1, TSR-042, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation.
ENGOT-Cx10/GEICO 68-C/BEAT CC (A Oaknin)
A Phase III Trial of Platinum Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Platinum Chemotherapy plus Paclitaxel and Bevacizumab in Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix.
ENGOT-Cx9/GEICO 72-C/Empower Cervical 1 (A Oaknin)
A phase 3 of REGN2810 versus therapy of investigators choice chemotherapy in recurrent or metastatic platinum-refractory CC.
MK3475-A18-ENGOT-cx11/GEICO 86-C (A Oaknin)
A Randomized, Phase 3, Double-Blind Study of Chemo-radiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer.
